Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Malavasi

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Leukocyte Biology|August 3, 2011
Editorial: CD38 and retinoids: a step toward a cureFabio Malavasi
Purinergic Signalling|April 12, 2008
The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymesSilvia Deaglio, Fabio Malavasi
Haematologica|June 2, 2009
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferationSilvia Deaglio, Fabio Malavasi
Frontiers in Immunology|September 3, 2019
Editorial: Immunotherapy in Multiple MyelomaNicola Giuliani, Fabio Malavasi
Biological Psychiatry|July 17, 2012
CD38 and behavior: moving from correlation to causality?Enrico Brunetti, Fabio Malavasi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2019
Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma ImmunotherapyFabio Malavasi, Angelo Corso Faini
Trends in Pharmacological Sciences|December 20, 2016
A Purinergic Trail for MetastasesDavide Ferrari, Fabio Malavasi, Luca Antonioli
Frontiers in Immunology|May 3, 2021
The Key Role of NAD<sup>+</sup> in Anti-Tumor Immune Response: An UpdateFabio Morandi, Alberto Leonardo Horenstein, Fabio Malavasi
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2005
Purification of clinical-grade monoclonal antibodies by chromatographic methodsAlberto L Horenstein, Ilaria Durelli, Fabio Malavasi
Immunology Letters|July 1, 2018
A phylogenetic view of the leukocyte ectonucleotidasesEnza Ferrero, Angelo C Faini, Fabio Malavasi
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Leukocyte Biology|August 3, 2011
Editorial: CD38 and retinoids: a step toward a cureFabio Malavasi
Purinergic Signalling|April 12, 2008
The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymesSilvia Deaglio, Fabio Malavasi
Haematologica|June 2, 2009
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferationSilvia Deaglio, Fabio Malavasi
Frontiers in Immunology|September 3, 2019
Editorial: Immunotherapy in Multiple MyelomaNicola Giuliani, Fabio Malavasi
Biological Psychiatry|July 17, 2012
CD38 and behavior: moving from correlation to causality?Enrico Brunetti, Fabio Malavasi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2019
Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma ImmunotherapyFabio Malavasi, Angelo Corso Faini
Trends in Pharmacological Sciences|December 20, 2016
A Purinergic Trail for MetastasesDavide Ferrari, Fabio Malavasi, Luca Antonioli
Frontiers in Immunology|May 3, 2021
The Key Role of NAD<sup>+</sup> in Anti-Tumor Immune Response: An UpdateFabio Morandi, Alberto Leonardo Horenstein, Fabio Malavasi
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2005
Purification of clinical-grade monoclonal antibodies by chromatographic methodsAlberto L Horenstein, Ilaria Durelli, Fabio Malavasi
Immunology Letters|July 1, 2018
A phylogenetic view of the leukocyte ectonucleotidasesEnza Ferrero, Angelo C Faini, Fabio Malavasi
Pageof 16